Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12967-022-03527-z.

Title:
Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 Axis | Journal of Translational Medicine
Description:
Background Our previous study has identified a novel circRNA (circDIDO1) that is down-regulated in gastric cancer (GC) and significantly inhibits GC progression. The purpose of this study is to identify the molecular mechanism for circDIDO1 and to evaluate the therapeutic effect of circDIDO1 in GC. Methods By combining bioinformatic analysis with RNA sequencing data, we predicted the potential target of circDIDO1 and further validated the regulatory mechanisms for its tumor suppressor function in GC. RIP assay, luciferase reporter assay and in vitro cell function assays were performed to analyze circDIDO1-regulated downstream target genes. For the therapeutic study, circDIDO1-loaded, RGD-modified exosomes (RGD-Exo-circDIDO1) were constructed and its anti-tumor efficacy and biological safety were evaluated in vitro and in vivo. Results CircDIDO1 inhibited GC progression by regulating the expression of the signal transducer inhibitor SOSC2 through sponging miR-1307-3p. Overexpression of circDIDO1 or SOSC2 antagonized the oncogenic role of miR-1307-3p. RGD-Exo-circDIDO1 could efficiently deliver circDIDO1 to increase SOCS2 expression in GC cells. Compared with PBS and RGD-Exo-vector treatment, RGD-Exo-circDIDO1 treatment significantly inhibited the proliferation, migration and invasion of GC cells while promoted cell apoptosis. The therapeutic efficacy of RGD-Exo-circDIDO1 was further confirmed in a mouse xenograft tumor model. In addition, major tissues including the heart, liver, spleen, lungs and kidneys showed no obvious histopathological abnormalities or lesions in the RGD-Exo-circDIDO1 treated group. Conclusion Our findings revealed that circDIDO1 suppressed the progression of GC via modulating the miR-1307-3p/SOSC2 axis. Systemic administration of RGD modified, circDIDO1 loaded exosomes repressed the tumorigenicity and aggressiveness of GC both in vitro and in vivo, suggesting that RGD-Exo-circDIDO1 could be used as a feasible nanomedicine for GC therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

circdido, pubmed, cancer, cells, article, mirp, google, scholar, exosomes, rgdexocircdido, cas, cell, socs, fig, progression, expression, rna, wang, data, zhang, delivery, gastric, tumor, tissues, central, analysis, results, treatment, effect, invasion, treated, circular, therapeutic, assay, shown, function, axis, study, luciferase, engineered, inhibits, reporter, migration, protein, usa, growth, vivo, pbs, significant, mice,

Topics {✒️}

targeting mir-203a-3p/socs3 axis circdido1/mir-1307-3p/socs2 signaling pathway mir-141-3p/pten/akt pathway triple-negative breast cancer including mir-196a/mir-196b [36] regulate socs2/jak/stat signaling mir-1307-3p/socs2 axis plays dendritic cell-derived exosomes wnt2/β-catenin pathway [31] dii-labeled rgd-exo-circdido1 scale bars = 100 μm scale bars = 60 μm rgd-exo-circdido1 treated group rgd-exo-circdido1 treatment led wnt2/beta-catenin pathway microrna-196a/-196b regulate article download pdf anti-cancer drug 5-fu relieving beta-cell destruction vivo β-catenin attenuation msc-derived exosomes loaded cell-penetrating inhibitory peptides mir-1307-3p/smg1 axis [33] mir-1307-3p/smg1 axis exosome-based rna delivery nano-scale size engineered exosome-based delivery rna-induced silencing complex engineered exosome-mediated delivery circdido1/mir-1307-3p axis mir-1307-3p/sosc2 axis mir-1307-3p/socs2 axis form rgd-exo-vector cytokine-induced signaling transduction extracellular membrane-derived vesicles extracellular vesicle-mediated delivery nf-κb regulator encoded facilitating hur-repressed functions rgd-exo-circdido1 ranged scale bar = 20 μm exosome-based circrna delivery rgd-exo-vector treatment reduce mir-142-3p levels human bladder cancer efficient anti-tumor effect rgd-exo-circdido1 treatment tissue-specific expression patterns rgd-engineered exosomes labeling ki-67-positive proliferating cells tunel-positive apoptotic cells

Questions {❓}

  • Is gastric cancer preventable?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 Axis
         description:Our previous study has identified a novel circRNA (circDIDO1) that is down-regulated in gastric cancer (GC) and significantly inhibits GC progression. The purpose of this study is to identify the molecular mechanism for circDIDO1 and to evaluate the therapeutic effect of circDIDO1 in GC. By combining bioinformatic analysis with RNA sequencing data, we predicted the potential target of circDIDO1 and further validated the regulatory mechanisms for its tumor suppressor function in GC. RIP assay, luciferase reporter assay and in vitro cell function assays were performed to analyze circDIDO1-regulated downstream target genes. For the therapeutic study, circDIDO1-loaded, RGD-modified exosomes (RGD-Exo-circDIDO1) were constructed and its anti-tumor efficacy and biological safety were evaluated in vitro and in vivo. CircDIDO1 inhibited GC progression by regulating the expression of the signal transducer inhibitor SOSC2 through sponging miR-1307-3p. Overexpression of circDIDO1 or SOSC2 antagonized the oncogenic role of miR-1307-3p. RGD-Exo-circDIDO1 could efficiently deliver circDIDO1 to increase SOCS2 expression in GC cells. Compared with PBS and RGD-Exo-vector treatment, RGD-Exo-circDIDO1 treatment significantly inhibited the proliferation, migration and invasion of GC cells while promoted cell apoptosis. The therapeutic efficacy of RGD-Exo-circDIDO1 was further confirmed in a mouse xenograft tumor model. In addition, major tissues including the heart, liver, spleen, lungs and kidneys showed no obvious histopathological abnormalities or lesions in the RGD-Exo-circDIDO1 treated group. Our findings revealed that circDIDO1 suppressed the progression of GC via modulating the miR-1307-3p/SOSC2 axis. Systemic administration of RGD modified, circDIDO1 loaded exosomes repressed the tumorigenicity and aggressiveness of GC both in vitro and in vivo, suggesting that RGD-Exo-circDIDO1 could be used as a feasible nanomedicine for GC therapy.
         datePublished:2022-07-21T00:00:00Z
         dateModified:2022-07-21T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12967-022-03527-z
         keywords:
            Gastric cancer
            CirDIDO1
            MiR-1307-3p
            SOCS2
            Exosomes
            Cancer therapy
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig8_HTML.png
         isPartOf:
            name:Journal of Translational Medicine
            issn:
               1479-5876
            volumeNumber:20
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zhen Guo
               affiliation:
                     name:Affiliated Aoyang Hospital of Jiangsu University
                     address:
                        name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Jiangsu University
                     address:
                        name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu Zhang
               affiliation:
                     name:Affiliated Aoyang Hospital of Jiangsu University
                     address:
                        name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Jiangsu University
                     address:
                        name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wenrong Xu
               affiliation:
                     name:Affiliated Aoyang Hospital of Jiangsu University
                     address:
                        name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Jiangsu University
                     address:
                        name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xu Zhang
               affiliation:
                     name:Affiliated Aoyang Hospital of Jiangsu University
                     address:
                        name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Jiangsu University
                     address:
                        name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jiajia Jiang
               affiliation:
                     name:Affiliated Aoyang Hospital of Jiangsu University
                     address:
                        name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Jiangsu University
                     address:
                        name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 Axis
      description:Our previous study has identified a novel circRNA (circDIDO1) that is down-regulated in gastric cancer (GC) and significantly inhibits GC progression. The purpose of this study is to identify the molecular mechanism for circDIDO1 and to evaluate the therapeutic effect of circDIDO1 in GC. By combining bioinformatic analysis with RNA sequencing data, we predicted the potential target of circDIDO1 and further validated the regulatory mechanisms for its tumor suppressor function in GC. RIP assay, luciferase reporter assay and in vitro cell function assays were performed to analyze circDIDO1-regulated downstream target genes. For the therapeutic study, circDIDO1-loaded, RGD-modified exosomes (RGD-Exo-circDIDO1) were constructed and its anti-tumor efficacy and biological safety were evaluated in vitro and in vivo. CircDIDO1 inhibited GC progression by regulating the expression of the signal transducer inhibitor SOSC2 through sponging miR-1307-3p. Overexpression of circDIDO1 or SOSC2 antagonized the oncogenic role of miR-1307-3p. RGD-Exo-circDIDO1 could efficiently deliver circDIDO1 to increase SOCS2 expression in GC cells. Compared with PBS and RGD-Exo-vector treatment, RGD-Exo-circDIDO1 treatment significantly inhibited the proliferation, migration and invasion of GC cells while promoted cell apoptosis. The therapeutic efficacy of RGD-Exo-circDIDO1 was further confirmed in a mouse xenograft tumor model. In addition, major tissues including the heart, liver, spleen, lungs and kidneys showed no obvious histopathological abnormalities or lesions in the RGD-Exo-circDIDO1 treated group. Our findings revealed that circDIDO1 suppressed the progression of GC via modulating the miR-1307-3p/SOSC2 axis. Systemic administration of RGD modified, circDIDO1 loaded exosomes repressed the tumorigenicity and aggressiveness of GC both in vitro and in vivo, suggesting that RGD-Exo-circDIDO1 could be used as a feasible nanomedicine for GC therapy.
      datePublished:2022-07-21T00:00:00Z
      dateModified:2022-07-21T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12967-022-03527-z
      keywords:
         Gastric cancer
         CirDIDO1
         MiR-1307-3p
         SOCS2
         Exosomes
         Cancer therapy
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-022-03527-z/MediaObjects/12967_2022_3527_Fig8_HTML.png
      isPartOf:
         name:Journal of Translational Medicine
         issn:
            1479-5876
         volumeNumber:20
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zhen Guo
            affiliation:
                  name:Affiliated Aoyang Hospital of Jiangsu University
                  address:
                     name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Jiangsu University
                  address:
                     name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu Zhang
            affiliation:
                  name:Affiliated Aoyang Hospital of Jiangsu University
                  address:
                     name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Jiangsu University
                  address:
                     name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wenrong Xu
            affiliation:
                  name:Affiliated Aoyang Hospital of Jiangsu University
                  address:
                     name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Jiangsu University
                  address:
                     name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xu Zhang
            affiliation:
                  name:Affiliated Aoyang Hospital of Jiangsu University
                  address:
                     name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Jiangsu University
                  address:
                     name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jiajia Jiang
            affiliation:
                  name:Affiliated Aoyang Hospital of Jiangsu University
                  address:
                     name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Jiangsu University
                  address:
                     name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Translational Medicine
      issn:
         1479-5876
      volumeNumber:20
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Affiliated Aoyang Hospital of Jiangsu University
      address:
         name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
         type:PostalAddress
      name:Jiangsu University
      address:
         name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
         type:PostalAddress
      name:Affiliated Aoyang Hospital of Jiangsu University
      address:
         name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
         type:PostalAddress
      name:Jiangsu University
      address:
         name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
         type:PostalAddress
      name:Affiliated Aoyang Hospital of Jiangsu University
      address:
         name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
         type:PostalAddress
      name:Jiangsu University
      address:
         name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
         type:PostalAddress
      name:Affiliated Aoyang Hospital of Jiangsu University
      address:
         name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
         type:PostalAddress
      name:Jiangsu University
      address:
         name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
         type:PostalAddress
      name:Affiliated Aoyang Hospital of Jiangsu University
      address:
         name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
         type:PostalAddress
      name:Jiangsu University
      address:
         name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zhen Guo
      affiliation:
            name:Affiliated Aoyang Hospital of Jiangsu University
            address:
               name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
               type:PostalAddress
            type:Organization
            name:Jiangsu University
            address:
               name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
               type:PostalAddress
            type:Organization
      name:Yu Zhang
      affiliation:
            name:Affiliated Aoyang Hospital of Jiangsu University
            address:
               name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
               type:PostalAddress
            type:Organization
            name:Jiangsu University
            address:
               name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
               type:PostalAddress
            type:Organization
      name:Wenrong Xu
      affiliation:
            name:Affiliated Aoyang Hospital of Jiangsu University
            address:
               name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
               type:PostalAddress
            type:Organization
            name:Jiangsu University
            address:
               name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
               type:PostalAddress
            type:Organization
      name:Xu Zhang
      affiliation:
            name:Affiliated Aoyang Hospital of Jiangsu University
            address:
               name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
               type:PostalAddress
            type:Organization
            name:Jiangsu University
            address:
               name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jiajia Jiang
      affiliation:
            name:Affiliated Aoyang Hospital of Jiangsu University
            address:
               name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
               type:PostalAddress
            type:Organization
            name:Jiangsu University
            address:
               name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
      name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
      name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
      name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
      name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
      name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
      name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
      name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
      name:Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, China
      name:Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China

External Links {🔗}(215)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.38s.